Cardiovascular Risk in People with HIV: New Risk Equations, New Guidelines, and Who Gets a Statin
The 2026 ACC/AHA/Multisociety Dyslipidemia Guideline recommends statin therapy for primary prevention of ASCVD for all people living with HIV (PLHIV) aged 40 to 75 years, independently of their traditional ASCVD risk score. This replaces previous calculator-based thresholds. On this episode, Antonio Urbina, MD, Medical Director for CEI’s HIV Primary Care and Prevention Center of Excellence, outlines the latest cardiovascular health guidelines for persons living with HIV. Related Content: CEI Line: 1-866-637-2342 https://ceitraining.org/ 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Conversations with CEI
Ditching the Script: Person-Centered Contraceptive Counseling
Anabolic Androgenic Steroids: Is “The Cycle” Addictive?
AIDS 2026 in Rio: What Came Out of the 26th International AIDS Conference
Updates on HSV Infection
Get summaries like this every morning.
Free AI-powered recaps of Conversations with CEI and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.